Liming Lin
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Ubiquitin and proteasome pathways 4
- RNA Interference and Gene Delivery 3
-
- Cardiac Fibrosis and Remodeling 4
- Cardiovascular Health and Risk Factors 4
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Guilan Quan (6 shared papers)Chuanbin Wu (6 shared papers)Chao Lü (6 shared papers)Rui Luo (5 shared papers)Dongyi Xian (4 shared papers)Yuwei Zheng (4 shared papers)Jinxiu Lin (7 shared papers)Xin Pan (4 shared papers)
- Journals
- International Immunopharmacology (3 papers)Acta Pharmaceutica Sinica B (2 papers)International Journal of Molecular Medicine (2 papers)International Journal of Biological Macromolecules (2 papers)ESC Heart Failure (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Liming Lin
63 papers receiving 882 citations
Peers
Comparison fields: 5 of 104
- Microbiology 114
- Pharmaceutical Science 37
- Cardiology and Cardiovascular Medicine 114
- Endocrinology 28
- Molecular Medicine 19
Countries citing papers authored by Liming Lin
This map shows the geographic impact of Liming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Lin more than expected).
Fields of papers citing papers by Liming Lin
This network shows the impact of papers produced by Liming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Lin. The network helps show where Liming Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2022 | 108 | |
| 3 | 2015 | 43 | |
| 4 | 2023 | 37 | |
| 5 | 2016 | 32 | |
| 6 | 2021 | 31 | |
| 7 | 2019 | 31 | |
| 8 | 2018 | 28 | |
| 9 | 2021 | 27 | |
| 10 | 2015 | 27 | |
| 11 | 2024 | 25 | |
| 12 | 2010 | 23 | |
| 13 | 2016 | 21 | |
| 14 | 2017 | 20 | |
| 15 | 2021 | 17 | |
| 16 | 2010 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2013 | 14 | |
| 19 | 2024 | 14 | |
| 20 | 2024 | 14 |
About Liming Lin
Liming Lin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Plant Science, Endocrinology, Diabetes and Metabolism and Surgery, having authored 70 papers that have together received 891 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (5 papers), Ubiquitin and proteasome pathways (4 papers), Cassava research and cyanide (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Cardiovascular Health and Risk Factors (4 papers), Plant Virus Research Studies (4 papers), Blood Pressure and Hypertension Studies (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Microbiology (114 citations), Pharmaceutical Science (37 citations), Cardiology and Cardiovascular Medicine (114 citations), Endocrinology (28 citations) and Molecular Medicine (19 citations). Liming Lin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guilan Quan, Chuanbin Wu, Chao Lü, Rui Luo, Dongyi Xian, Yuwei Zheng, Jinxiu Lin, Xin Pan, Meifang Wu and Xiaoqian Feng. Their work appears in journals such as International Immunopharmacology, Acta Pharmaceutica Sinica B, International Journal of Molecular Medicine, International Journal of Biological Macromolecules and ESC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.